Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bliv vs Enhance MD

Bliv
Site position #348

Lower grade

vs+23.9
Enhance MD
Site position #5

Higher grade

The verdict

Enhance MD takes it — 84.8/100 to 60.9/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEnhance MD +11
71
82
Dose & formulationEnhance MD +18
64
82
Clinical oversightEnhance MD +33
55
88
Labs & monitoringEnhance MD +37
53
90
FulfillmentEnhance MD +19
65
84
Contract termsEnhance MD +39
45
84
Bliv · left barEnhance MD · right bar

The numbers

MetricBlivEnhance MD
WeighScore60.9/10084.8/100
GradeCB
Site position#348#5
Semaglutide$116/mo (as low as, varies by plan and eligibility, compounded)$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay
Tirzepatide$199/mo (as low as, varies by plan and eligibility, compounded)$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay
CoverageCoverage not publishedNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Bliv

Site position #348 · C

FDAWarning letter issued to Bliv Wellness LLC dba Bliv in February 2026. See the FDA warning-letter database.

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
  • A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
  • The homepage advertises 'no long-term commitments or cancellation fees' while the terms require the membership fee to be paid 'in a single sum', call it non-refundable and refer to a 'Membership Term'
  • The only figure smaller than the advertised rate is a $29 CareCredit/Klarna installment, which is a financing payment rather than the price of a month of medication
  • FDA issued Bliv Wellness LLC dba Bliv a warning letter in February 2026; the letter is public in FDA's warning-letter database
Enhance MD

Site position #5 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs

Featured provider

Enhance MD

Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard